BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

642 related articles for article (PubMed ID: 27531536)

  • 1. Helicobacter pylori and non-malignant upper gastrointestinal diseases.
    Vasapolli R; Malfertheiner P; Kandulski A
    Helicobacter; 2016 Sep; 21 Suppl 1():30-3. PubMed ID: 27531536
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Helicobacter pylori infection and nonmalignant diseases.
    Sjomina O; Heluwaert F; Moussata D; Leja M
    Helicobacter; 2017 Sep; 22 Suppl 1():. PubMed ID: 28891136
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Endoscopic and histopathological findings of the upper gastrointestinal tract in patients with functional and organic dyspepsia].
    Piatek-Guziewicz A; Przybylska-Feluś M; Dynowski W; Zwolińska-Wcisło M; Lickiewicz J; Mach T
    Przegl Lek; 2014; 71(4):204-9. PubMed ID: 25141579
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Helicobacter pylori and non-malignant diseases.
    Matysiak-Budnik T; Laszewicz W; Lamarque D; Chaussade S
    Helicobacter; 2006 Oct; 11 Suppl 1():27-31. PubMed ID: 16925608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Symptomatic benefit 1-3 years after H. pylori eradication in ulcer patients: impact of gastroesophageal reflux disease.
    McColl KE; Dickson A; El-Nujumi A; El-Omar E; Kelman A
    Am J Gastroenterol; 2000 Jan; 95(1):101-5. PubMed ID: 10638566
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Long-term course of reflux symptoms following Helicobacter pylori eradication].
    Peitz U; Raps S; Plein K; Leodolter A; Hotz Dagger J; Malfertheiner P
    Dtsch Med Wochenschr; 2004 Mar; 129(13):671-5. PubMed ID: 15026962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gastroesophageal Reflux Disease in Time Covering Eradication for All Patients Infected with Helicobacter pylori in Japan.
    Sugimoto M; Uotani T; Ichikawa H; Andoh A; Furuta T
    Digestion; 2016; 93(1):24-31. PubMed ID: 26789391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Peptic ulcer and Helicobacter pyrlori. Results and consequences of its eradication].
    Ballesteros-Amozurrutia MA
    Rev Gastroenterol Mex; 2000; 65(4 Suppl 2):41-9. PubMed ID: 11464621
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endoscopic and histological findings and Helicobacter pylori status in patients with reflux and/or dyspeptic symptoms: a recent Greek cohort study.
    Vasiliou C; Xiromeritou V; Kafiri G; Papatheodoridis G
    Gastroenterol Nurs; 2014; 37(6):431-8. PubMed ID: 25461465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of non-steroidal anti-inflammatory drug and aspirin use on the prevalence of dyspepsia and uncomplicated peptic ulcer disease.
    Voutilainen M; Mäntynen T; Färkkilä M; Juhola M; Sipponen P
    Scand J Gastroenterol; 2001 Aug; 36(8):817-21. PubMed ID: 11495076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Helicobacter pylori and Nonmalignant Diseases.
    Potamitis GS; Axon AT
    Helicobacter; 2015 Sep; 20 Suppl 1():26-9. PubMed ID: 26372821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patients with dyspepsia benefit from eradication of Helicobacter pylori if other organic causes for dyspepsia were carefully ruled out.
    Bojarski C; Epple HJ; Kirstein FW; Fromm M; Bisson S; Riecken EO; Schulzke JD
    Z Gastroenterol; 2000 Mar; 38(3):211-9. PubMed ID: 10768243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dyspepsia, peptic ulcer, and H. pylori: a remembrance of things past.
    Vakil N
    Am J Gastroenterol; 2010 Mar; 105(3):572-4. PubMed ID: 20203639
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Helicobacter pylori-negative gastritis in erosive esophagitis, nonerosive reflux disease or functional dyspepsia patients.
    Peura DA; Haber MM; Hunt B; Atkinson S
    J Clin Gastroenterol; 2010 Mar; 44(3):180-5. PubMed ID: 19687753
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gastroesophageal reflux disease: prevalence, clinical, endoscopic and histopathological findings in 1,128 consecutive patients referred for endoscopy due to dyspeptic and reflux symptoms.
    Voutilainen M; Sipponen P; Mecklin JP; Juhola M; Färkkilä M
    Digestion; 2000; 61(1):6-13. PubMed ID: 10671769
    [TBL] [Abstract][Full Text] [Related]  

  • 16. H pylori infection among 1000 southern Iranian dyspeptic patients.
    Hashemi MR; Rahnavardi M; Bikdeli B; Dehghani Zahedani M
    World J Gastroenterol; 2006 Sep; 12(34):5479-82. PubMed ID: 17006984
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Upper gastro-intestinal disease in Scotland: a survey of practice amongst Scottish gastroenterologists.
    Kubba AK; Whyman MR
    J R Coll Surg Edinb; 1996 Oct; 41(5):302-6. PubMed ID: 8908952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Dyspepsia and Helicobacter pylori infection in employees of a large industry. Results of a prospective BASF Helicobacter pylori prevention campaign].
    Schilling D; Messerer P; Ott MG; Schauwecker P; Zober A; Riemann JF
    Med Klin (Munich); 2002 Jan; 97(1):6-11. PubMed ID: 11831064
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Helicobacter pylori infection, pattern of gastritis, and symptoms in erosive and nonerosive gastroesophageal reflux disease.
    Manes G; Mosca S; Laccetti M; Lioniello M; Balzano A
    Scand J Gastroenterol; 1999 Jul; 34(7):658-62. PubMed ID: 10466875
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 33.